checkmate 649 biomarker analyses of nivo ipi vs chemo for patients with gc/gejc/eac
Published 1 year ago • 110 plays • Length 6:31Download video MP4
Download video MP3
Similar videos
-
1:44
checkmate 649: nivolumab and chemotherapy or ipilimumab in gc/gejc/eac
-
1:22
3-year follow-up of checkmate 649: nivolumab chemotherapy in gc/gejc/eac
-
8:38
checkmate 459: nivolumab plus chemotherapy for gc / gejc / eac
-
6:54
checkmate 649: 1l nivo chemotherapy improves os
-
4:47
nivolumab chemotherapy combination treatment: checkmate649 and attraction-4
-
9:32
checkmate 648: nivolumab plus ipilimumab or nivo plus chemo versus chemo as (1l) treatment for a...
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
2:28
jaffer ajani, md, considers results from the checkmate 649 study presented at esmo 2020
-
3:52
understanding your biomarker test report
-
2:10
biomarker analyses from checkmate 648
-
6:04
checkmate 816 trial: nivolumab platinum-doublet chemotherapy vs chemo as neoadjuvant treatment...
-
3:19
geoffrey y. ku, md, offers opinion on the practice-changing potential of the checkmate-649 study
-
8:20
dr. gordon moe: "how to use biomarkers for your heart failure patients"
-
51:57
ca cancer caucus legislative briefing on biomarker testing
-
7:38
deliver trial: blood based biomarker analysis of patients with gastric cancer treated with nivolumab
-
4:05
checkmate 9la: first-line nivolumab ipilimumab 2 cycles chemotherapy vs 4 cycles chemo in an...
-
0:54
the role of biomarkers in gastric cancers
-
14:12
adding immunotherapy to first-line chemotherapy for gastric cancer: data and implications
-
3:21
how is gastric cancer biomarker testing conducted?